July 19, 2021 — The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for…
Home ยป
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
China approves a fourth COVID-19 vaccine for emergency use
China has approved a new COVID-19 vaccine for emergency use, one that was developed by the head of its Center…
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.…
FDA Approves Breyanzi
FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma PRINCETON, N.J.–(BUSINESS WIRE)…
FDA Approves Posimir
FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression CUPERTINO, Calif., Feb.…
Egypt approves Chinese Sinopharm COVID-19 vaccine
Egypt has approved the use of a COVID-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start…
US approves Regeneron antibody treatment given to Trump
A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for…
FDA Approves Palforzia
FDA Approves Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] as First Treatment for Peanut Allergy BRISBANE, Calif.–(BUSINESS WIRE)–Jan. 31, 2020– Aimmune…
FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
KENILWORTH, N.J.–(BUSINESS WIRE) February 19, 2019 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced…